PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors

Name: PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
Published: 2022
License: Public Domain

Pfizer · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

gastric-cancer immunotherapy non-small-cell-lung-cancer nsclc

advanced solid tumors, gastric cancer, gastroesophageal junction cancer, urothelial cancer, non small cell lung cancer, head and neck squamous cell carcinomas, immunotherapy, advanced solid tumor, metastatic solid tumor, first in human, scchn, nsclc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 905590
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.